TIANJIN DEV (00882): Tianjin Lisheng Pharmaceutical's net profit attributable to shareholders for the first three quarters was RMB78.51 million, down 78.82% year-on-year.
TIANJIN DEV (00882) announced the results of Tianjin Lisheng Pharmaceutical for the nine months ended September 30, 2026, with total operating revenue of RMB888 million, down 11.84% year-on-year; net profit attributable to owners of the parent company of RMB78.51 million, down 78.82% year-on-year; and basic earnings per share of RMB0.25.
TIANJIN DEV (00882) announced the results of Tianjin Lisheng Pharmaceutical for the nine months ended September 30, 2026, with total operating revenue of RMB888 million, down 11.84% year-on-year; net profit attributable to owners of the parent company of RMB78.51 million, down 78.82% year-on-year; and basic earnings per share of RMB0.25.
Related Articles
.png)
PLAYMATES TOYS (00869) repurchased 300,000 shares for HK$144,000 on October 26.

GAPACK (00468) attributable profit to shareholders for the first three quarters was RMB14.223 million, down 81.52% year-on-year.

POLY PROPERTY (00119): Shanghai Poly Property recorded a net loss attributable to shareholders of RMB816 million in the first nine months, turning from profit to loss year-on-year.
PLAYMATES TOYS (00869) repurchased 300,000 shares for HK$144,000 on October 26.
.png)
GAPACK (00468) attributable profit to shareholders for the first three quarters was RMB14.223 million, down 81.52% year-on-year.

POLY PROPERTY (00119): Shanghai Poly Property recorded a net loss attributable to shareholders of RMB816 million in the first nine months, turning from profit to loss year-on-year.






